Source: FASEB Journal. Conference titles: Experimental Biology. Unidade: FM
Subjects: ENDOTÉLIO, STREPTOMYCES, FÁRMACOS IMUNOSSUPRESSORES
ABNT
GIRAO-SILVA, Thais et al. Rapamycin Activates TGF Receptor Independently of Its Ligands: Implications for Endothelial Dysfunction. FASEB Journal. Bethesda: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.fasebj.org/content/29/1_Supplement/642.9.abstract?sid=ca8af828-e551-498f-9c94-c823865685d6. Acesso em: 22 jul. 2024. , 2015APA
Girao-Silva, T., Miyakawa, A., Krieger, J., & Edelman, E. (2015). Rapamycin Activates TGF Receptor Independently of Its Ligands: Implications for Endothelial Dysfunction. FASEB Journal. Bethesda: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.fasebj.org/content/29/1_Supplement/642.9.abstract?sid=ca8af828-e551-498f-9c94-c823865685d6NLM
Girao-Silva T, Miyakawa A, Krieger J, Edelman E. Rapamycin Activates TGF Receptor Independently of Its Ligands: Implications for Endothelial Dysfunction [Internet]. FASEB Journal. 2015 ; 29( 1):[citado 2024 jul. 22 ] Available from: http://www.fasebj.org/content/29/1_Supplement/642.9.abstract?sid=ca8af828-e551-498f-9c94-c823865685d6Vancouver
Girao-Silva T, Miyakawa A, Krieger J, Edelman E. Rapamycin Activates TGF Receptor Independently of Its Ligands: Implications for Endothelial Dysfunction [Internet]. FASEB Journal. 2015 ; 29( 1):[citado 2024 jul. 22 ] Available from: http://www.fasebj.org/content/29/1_Supplement/642.9.abstract?sid=ca8af828-e551-498f-9c94-c823865685d6